Kuhad, Anurag <br/><br/>
Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits.  [electronic resource] 

 -  Pharmacology, biochemistry, and behavior  Apr 2009 
 - 251-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0091-3057 
<br/><br/><label>Standard No.: </label>10.1016/j.pbb.2008.12.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Glucose--analysis<br/>Cognition Disorders--complications<br/>Diabetes Mellitus, Experimental--complications<br/>Insulin--blood<br/>Lipid Peroxidation--drug effects<br/>NF-kappa B--antagonists & inhibitors<br/>Rats<br/>Signal Transduction--drug effects<br/>Streptozocin<br/>Tocotrienols--pharmacology